SFBC International has changed its name to PharmaNet Development Group, Inc. after receiving approval from its shareholders at the annual meeting. The company has also named John P. Hamill to the role of executive vice president and chief financial officer, David Natan to executive vice president, Reporting and Analysis, and chief accounting officer, and Thomas J. Newman, M.D. to executive vice president, Late Stage Development. Dr. Newman will retain his responsibilities as chief operating offi...